C4 glomerulopathy causes: Difference between revisions

Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
C4 glomerulopathy may be caused by mutation of complement factor,anti-factor H, anti-factor B, or C4 nephritic factor.


==Causes==
==Causes==
Common causes of is not yet known but C4 glomerulopathy is analogous to C3 glomerulopathy and the causes may include<ref name="pmid15163532">{{cite journal |vauthors=Rodríguez de Córdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sánchez-Corral P |title=The human complement factor H: functional roles, genetic variations and disease associations |journal=Mol. Immunol. |volume=41 |issue=4 |pages=355–67 |date=June 2004 |pmid=15163532 |doi=10.1016/j.molimm.2004.02.005 |url=}}</ref><ref name="pmid29948306">{{cite journal |vauthors=Noris M, Donadelli R, Remuzzi G |title=Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy |journal=Pediatr. Nephrol. |volume= |issue= |pages= |date=June 2018 |pmid=29948306 |doi=10.1007/s00467-018-3989-0 |url=}}</ref><ref name="pmid28096309">{{cite journal| author=Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J | display-authors=etal| title=Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN. | journal=J Am Soc Nephrol | year= 2017 | volume= 28 | issue= 5 | pages= 1603-1613 | pmid=28096309 | doi=10.1681/ASN.2016030343 | pmc=5407719 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28096309  }} </ref><ref name="pmid28838767">{{cite journal| author=Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G | display-authors=etal| title=C4 Nephritic Factors in C3 Glomerulopathy: A Case Series. | journal=Am J Kidney Dis | year= 2017 | volume= 70 | issue= 6 | pages= 834-843 | pmid=28838767 | doi=10.1053/j.ajkd.2017.07.004 | pmc=5701858 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28838767  }} </ref><ref name="pmid25917093">{{cite journal| author=Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M | display-authors=etal| title=Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases. | journal=J Immunol | year= 2015 | volume= 194 | issue= 11 | pages= 5129-38 | pmid=25917093 | doi=10.4049/jimmunol.1402770 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25917093  }} </ref>:
Common causes of is not yet known but C4 glomerulopathy is analogous to C3 glomerulopathy and the causes may include<ref name="pmid15163532">{{cite journal |vauthors=Rodríguez de Córdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sánchez-Corral P |title=The human complement factor H: functional roles, genetic variations and disease associations |journal=Mol. Immunol. |volume=41 |issue=4 |pages=355–67 |date=June 2004 |pmid=15163532 |doi=10.1016/j.molimm.2004.02.005 |url=}}</ref><ref name="pmid29948306">{{cite journal |vauthors=Noris M, Donadelli R, Remuzzi G |title=Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy |journal=Pediatr. Nephrol. |volume= |issue= |pages= |date=June 2018 |pmid=29948306 |doi=10.1007/s00467-018-3989-0 |url=}}</ref><ref name="pmid28096309">{{cite journal| author=Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J | display-authors=etal| title=Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN. | journal=J Am Soc Nephrol | year= 2017 | volume= 28 | issue= 5 | pages= 1603-1613 | pmid=28096309 | doi=10.1681/ASN.2016030343 | pmc=5407719 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28096309  }} </ref><ref name="pmid28838767">{{cite journal| author=Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G | display-authors=etal| title=C4 Nephritic Factors in C3 Glomerulopathy: A Case Series. | journal=Am J Kidney Dis | year= 2017 | volume= 70 | issue= 6 | pages= 834-843 | pmid=28838767 | doi=10.1053/j.ajkd.2017.07.004 | pmc=5701858 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28838767  }} </ref><ref name="pmid25917093">{{cite journal| author=Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M | display-authors=etal| title=Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases. | journal=J Immunol | year= 2015 | volume= 194 | issue= 11 | pages= 5129-38 | pmid=25917093 | doi=10.4049/jimmunol.1402770 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25917093  }} </ref>:
* C4 Nephritic factor-an autoantibody against C4 can cause complement dysregulation against immune complex-myeloproliferative glomerulonephritic patients.
* C4 nephritic factor-an autoantibody against C4 can cause complement dysregulation against immune complex-myeloproliferative glomerulonephritic patients.
*[[Mutation]] of complement factor H (CFH).
*[[Mutation]] of complement factor H (CFH).
** CFH is a small glycoprotein that is produced in the [[liver]] and circulates freely in the [[blood plasma]].  
** CFH is a small glycoprotein that is produced in the [[liver]] and circulates freely in the [[blood plasma]].  

Latest revision as of 03:51, 8 August 2020

C4 glomerulopathy Microchapters

Complement Mediated Glomerular Disorders Main Page

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating C4 glomerulopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

C4 glomerulopathy causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of C4 glomerulopathy causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on C4 glomerulopathy causes

CDC on C4 glomerulopathy causes

C4 glomerulopathy causes in the news

Blogs on C4 glomerulopathy causes

Directions to Hospitals Treating C4 glomerulopathy

Risk calculators and risk factors for C4 glomerulopathy causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]

Overview

C4 glomerulopathy may be caused by mutation of complement factor,anti-factor H, anti-factor B, or C4 nephritic factor.

Causes

Common causes of is not yet known but C4 glomerulopathy is analogous to C3 glomerulopathy and the causes may include[1][2][3][4][5]:

  • C4 nephritic factor-an autoantibody against C4 can cause complement dysregulation against immune complex-myeloproliferative glomerulonephritic patients.
  • Mutation of complement factor H (CFH).
  • Anti-Factor H, anti-Factor B, and C3- or C4 nephritic factors are frequently seen in patients with complement-mediated renal disorders.
  • Mutation of membrane cofactor protein (MCP).

References

  1. Rodríguez de Córdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sánchez-Corral P (June 2004). "The human complement factor H: functional roles, genetic variations and disease associations". Mol. Immunol. 41 (4): 355–67. doi:10.1016/j.molimm.2004.02.005. PMID 15163532.
  2. Noris M, Donadelli R, Remuzzi G (June 2018). "Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy". Pediatr. Nephrol. doi:10.1007/s00467-018-3989-0. PMID 29948306.
  3. Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J; et al. (2017). "Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN". J Am Soc Nephrol. 28 (5): 1603–1613. doi:10.1681/ASN.2016030343. PMC 5407719. PMID 28096309.
  4. Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G; et al. (2017). "C4 Nephritic Factors in C3 Glomerulopathy: A Case Series". Am J Kidney Dis. 70 (6): 834–843. doi:10.1053/j.ajkd.2017.07.004. PMC 5701858. PMID 28838767.
  5. Blanc C, Togarsimalemath SK, Chauvet S, Le Quintrec M, Moulin B, Buchler M; et al. (2015). "Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases". J Immunol. 194 (11): 5129–38. doi:10.4049/jimmunol.1402770. PMID 25917093.

Template:WHTemplate:WS